Autoinflammatory
![](https://pbs.twimg.com/profile_images/1052210107394809856/InxUxKTZ.jpg)
1 year 1 month ago
EULAR/PRES recos for sJIA & AOSD
🔹sJIA = AOSD l
👉 Unique name: Still’s disease
🔹Start IL1i or IL6i as soon as diagnosis made
🔹MAS ⚠️
🔹Emerging issue: lung disease
👉Screening (HRCT if suspicion)
#EULAR2023
Pr B Fautrel & F deBenedetti
Key slides 👇🏼
NZ https://t.co/x1Snf8WI99
![](https://pbs.twimg.com/media/FxttZPmXwAgnGzf.jpg)
![](https://pbs.twimg.com/profile_images/1215290012490702848/mq73skc3.jpg)
1 year 1 month ago
AOSD: Young vs. Elderly Onset AOSDis an autoinflammatory condition characterized by fevers, arthritis, and rash. It is considered an orphan disease because of its low prevalence - it is reported anywhere between 16 to 40 per ten million. https://t.co/bB2mpul3j7 https://t.co/ic6mY04ddF
![](https://pbs.twimg.com/media/Fx39JG8XwAYR5So.jpg)
![](https://pbs.twimg.com/profile_images/1215290012490702848/mq73skc3.jpg)
1 year 1 month ago
AOSD: Young vs. Elderly Onset
AOSDis an autoinflammatory condition characterized by fevers, arthritis, and rash. It is considered an orphan disease because of its low prevalence - it is reported anywhere between 16 to 40 per ten million.
https://t.co/PPI1fvwLAf https://t.co/qMXMsbpwl3
![](https://pbs.twimg.com/media/FxtcEG8X0AAD2UV.jpg)
![](https://pbs.twimg.com/profile_images/1659729373426241536/tnA2hRe4.jpg)
1 year 1 month ago
@eular_org recommendations session #EULAR2023 - and the first recommendation is one I’m so glad is up front:
Adult Onset Still’s Disease (AOSD) and Systemic JIA (sJIA) are the same disease.
If anything, it’s the really young sJIA (<18 months old) which is different @RheumNow https://t.co/OCDeeNtNoR
![](https://pbs.twimg.com/media/FxsMQlOagAA2HN4.jpg)
![](https://pbs.twimg.com/profile_images/1659729373426241536/tnA2hRe4.jpg)
1 year 1 month ago
@eular_org recommendation for AOSD/sJIA:
An IL-1 or IL-6 inhibitor should be initiated as early as possible when the diagnosis is established
#EULAR2023 @RheumNow https://t.co/xNUdpGDxb9
![](https://pbs.twimg.com/media/FxsNFsEaYAIT80k.jpg)
![](https://pbs.twimg.com/profile_images/1248272740831735809/C0SA-iJf.jpg)
1 year 1 month ago
Microvascular visualization in Behcet's disease by ultrasound. Maybe really useful in cases which are difficult to diagnose and may not need biopsies in some pts.
#EULAR2023 @RheumNow https://t.co/PbC3tCe7v6
![](https://pbs.twimg.com/media/FxskTe2XsAE11q9.jpg)
![](https://pbs.twimg.com/profile_images/1625445768768135171/M24lCgC_.jpg)
1 year 1 month ago
#EULAR2023 Clinical Highlights. Vasculitis: OP0061 - new US imaging showing vessel inflammation differentiating patients with Behcet’s vs No-BD. OP0304: cohort study showed Benralizumab (IL5 RA) given for eosinophilic asthma also improved BVAS. RCT for EGPA is ongoing @RheumNow https://t.co/7uohfjGk49
![](https://pbs.twimg.com/media/FxsnKrtXgAEd3tO.jpg)
![](https://pbs.twimg.com/profile_images/1215290012490702848/mq73skc3.jpg)
1 year 1 month ago
Tune it at 1pm EST for RheumNow's daily #EULAR23 recaps. You can find us live on Twitter, YouTube and LinkedIn. https://t.co/t531csjXo8
![](https://pbs.twimg.com/media/Fxn271FWYAQ1Gp8.jpg)
![](https://pbs.twimg.com/profile_images/1248272740831735809/C0SA-iJf.jpg)
1 year 1 month ago
Long term data on Canakinumab - IL-1B antibody in #AOSD @EULAR2023 25 pts with persistent disease activity, f/u 12 mths, remission in all but 2 pts. Improved parameters as below :-
@rheumnow abst#OP0257 https://t.co/7jKTp87FlX
![](https://pbs.twimg.com/media/FxUvRnpWwAgbGnc.png)